Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Head and Neck Cancer

  Free Subscription


02.04.2018

1 Ann Surg
3 Anticancer Res
3 BMC Cancer
2 Br J Oral Maxillofac Surg
1 Cancer
1 Clin Cancer Res
6 Head Neck
2 Int J Cancer
1 J Clin Oncol
1 Laryngoscope
9 Oral Oncol
1 Surgery
8 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. KIYOZUMI Y, Baba Y, Okadome K, Yagi T, et al
    IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2018 Mar 27. doi: 10.1097/SLA.0000000000002754.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. FARINA E, Capuccini J, Macchia G, Caravatta L, et al
    Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer.
    Anticancer Res. 2018;38:2409-2414.
    PubMed     Text format     Abstract available

  3. SHIMAKAWA T, Naritaka Y, Asaka S, Miyazawa M, et al
    Innovations for Cervical Esophagogastrostomy in Thoracic Esophageal Cancer Operations.
    Anticancer Res. 2018;38:2323-2327.
    PubMed     Text format     Abstract available

  4. SHIH LC, Li CH, Sun KT, Chen LY, et al
    Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
    Anticancer Res. 2018;38:2087-2092.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. SETAKORNNUKUL J, Thephamongkhol K
    Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:329.
    PubMed     Text format     Abstract available

  6. CHO YJ, Kim DY, Park EC, Han KT, et al
    Thyroid fine-needle aspiration biopsy positively correlates with increased diagnosis of thyroid cancer in South Korean patients.
    BMC Cancer. 2017;17:114.
    PubMed     Text format     Abstract available

  7. PENG H, Tang LL, Liu X, Chen L, et al
    Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis.
    BMC Cancer. 2018;18:323.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  8. AZIMI S, Rafieian N, Manifar S, Ghorbani Z, et al
    Socioeconomic determinants as risk factors for squamous cell carcinoma of the head and neck: a case-control study in Iran.
    Br J Oral Maxillofac Surg. 2018 Mar 26. pii: S0266-4356(18)30058.
    PubMed     Text format     Abstract available

  9. VUITY D, McMahon J, Takhiuddin S, Slinger C, et al
    Is the 8th edition of the Union for International Cancer Control staging of oral cancer good enough?
    Br J Oral Maxillofac Surg. 2018 Mar 22. pii: S0266-4356(18)30038.
    PubMed     Text format     Abstract available


    Cancer

  10. HU J, Bao C, Gao J, Guan X, et al
    Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31318.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  11. XU C, Nikolova O, Basom R, Mitchell RM, et al
    Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer.
    Clin Cancer Res. 2018 Mar 29. pii: 1078-0432.CCR-17-1339.
    PubMed     Text format     Abstract available


    Head Neck

  12. KIM HK, Lee I, Lee J, Chang HS, et al
    BRAF(wild) papillary thyroid carcinoma has two distinct mRNA expression patterns with different clinical behaviors.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25151.
    PubMed     Text format     Abstract available

  13. HEGDE JV, Demanes DJ, Veruttipong D, Chin RK, et al
    Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25137.
    PubMed     Text format     Abstract available

  14. LUCIONI M, Lionello M, Salis G, Bertolin A, et al
    Bocca's hemipharyngo-total laryngectomy for hypopharyngeal carcinoma to avoid reconstruction with a pedicled flap.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25124.
    PubMed     Text format     Abstract available

  15. HAQUE SU, Niu L, Kuhnell D, Hendershot J, et al
    Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 25. doi: 10.1002/hed.25136.
    PubMed     Text format     Abstract available

  16. SHINGLER E, Robles LA, Perry R, Penfold C, et al
    Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.
    Head Neck. 2018 Mar 30. doi: 10.1002/hed.25138.
    PubMed     Text format     Abstract available

  17. RHOTEN BA, Murphy BA, Dietrich MS, Ridner SH, et al
    Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25129.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
    Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
    PubMed     Text format     Abstract available

  19. ARTHUR AE, Goss AM, Demark-Wahnefried W, Mondul AM, et al
    Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: Results from a prospective cohort study.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31413.
    PubMed     Text format     Abstract available


    J Clin Oncol

  20. MA BBY, Lim WT, Goh BC, Hui EP, et al
    Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).
    J Clin Oncol. 2018 Mar 27:JCO2017770388. doi: 10.1200/JCO.2017.77.0388.
    PubMed     Text format     Abstract available


    Laryngoscope

  21. VELEZ MA, Veruttipong D, Wang PC, Abemayor E, et al
    FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.
    Laryngoscope. 2018 Mar 24. doi: 10.1002/lary.27173.
    PubMed     Text format     Abstract available


    Oral Oncol

  22. KAMAL M, Ng SP, Eraj SA, Rock CD, et al
    Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.
    Oral Oncol. 2018;79:1-8.
    PubMed     Text format     Abstract available

  23. VAISANEN JA, Alho OP, Koivunen PT, Laara E, et al
    Cause-specific mortality in patients with head and neck cancer: Long-term follow-up of a population-based cohort from 1986 to 2012 accounting for competing risks.
    Oral Oncol. 2018;79:20-26.
    PubMed     Text format     Abstract available

  24. CAO C, Jiang F, Jin Q, Jin T, et al
    Locoregional extension and patterns of failure for nasopharyngeal carcinoma with intracranial extension.
    Oral Oncol. 2018;79:27-32.
    PubMed     Text format     Abstract available

  25. PENG H, Tang LL, Chen BB, Chen L, et al
    Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysis.
    Oral Oncol. 2018;79:40-46.
    PubMed     Text format     Abstract available

  26. BROGLIE MA, Jochum W, Michel A, Waterboer T, et al
    Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer.
    Oral Oncol. 2017;70:43-50.
    PubMed     Text format     Abstract available

  27. PORCEDDU SV, Milne R, Brown E, Bernard A, et al
    Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
    Oral Oncol. 2017;66:81-86.
    PubMed     Text format     Abstract available

  28. DODD RH, Forster AS, Waller J, Marlow LAV, et al
    Discussing HPV with oropharyngeal cancer patients: A cross-sectional survey of attitudes in health professionals.
    Oral Oncol. 2017;68:67-73.
    PubMed     Text format     Abstract available

  29. GARCIA-ESCUDERO R, Segrelles C, Duenas M, Pombo M, et al
    Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
    Oral Oncol. 2018;79:55-63.
    PubMed     Text format     Abstract available

  30. SABER CN, Gronhoj Larsen C, Dalianis T, von Buchwald C, et al
    Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature.
    Oral Oncol. 2016;58:8-13.
    PubMed     Text format     Abstract available


    Surgery

  31. MIYASHITA T, Kono T, Matsui D, Yamazaki Y, et al
    Preventive effect of oral hangeshashinto (TJ-14) on the development of reflux-induced esophageal cancer.
    Surgery. 2018 Mar 22. pii: S0039-6060(18)30037.
    PubMed     Text format     Abstract available


    Thyroid

  32. BRITO JP, Bleyer A
    Impact of thyroid cancer on the incidence and survival of adolescents and young adults with cancer.
    Thyroid. 2016.
    PubMed     Text format    

  33. ROSARIO PW
    Re: "A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma" by Jeon et al. (Thyroid 2018;28:187-192).
    Thyroid. 2018 Mar 27. doi: 10.1089/thy.2017.0644.
    PubMed     Text format    

  34. BRITO JP, Kim HJ, Han SJ, Lee YS, et al
    Geographic distribution and evolution of thyroid cancer epidemic in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available

  35. HAKALA TT, Kholova I
    Changes in classification of follicular thyroid cancers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available

  36. KIST JW, de Keizer B, Vogel WV
    Letter to the Editor regarding the article "I-124 PET/CT in patients with differentiated thyroid cancer: clinical and quantitative image analysis".
    Thyroid. 2016.
    PubMed     Text format    

  37. JINDAL A, Khan U
    Is Thyroglobulin level by LC-MS/MS always reliable for follow-up of DTC after Thyroidectomy: A report of 2 cases.
    Thyroid. 2016.
    PubMed     Text format     Abstract available

  38. GULEC SA, Kuker RA
    The Clinical Value of I-124 PET/CT Imaging in Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format    

  39. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: